The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

Marty Makary's resignation leaves the agency with temporary directors in three top positions, and a number of newly instituted policies with an unclear future.

Dr. Marty Makary's resignation from his post atop the Food and Drug Administration is widening a leadership gap that already existed at the U.S.

They called for stability and predictability at the agency at Axios' Future of Health summit.

Brought in as an agency critic, the commissioner drew fire from drug developers and abortion foes.

With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across biopharma have joined in support of the FDA’s former top…

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA. | With the ink barely dry on outgoing…

Dr. Tracy Beth Høeg is leaving her role as head of the FDA’s Center for Drug Evaluation and Research, just days after FDA chief Marty Makary resigned.

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.

The Food and Drug Administration's top drug official is leaving in the latest shake-up at the powerful health agency. Dr.

Tracey Beth Hoeg was fired as FDA drug division chief amid a broader Trump administration shake-up at the health department.

The U.S. Food and Drug Administration's drug center sees a leadership change as acting head Tracy Beth Hoeg departs, replaced by deputy Michael Davis. This follows Commissioner…

The FDA commissioner influences vaccines, medicines, food safety, nicotine regulation, and public trust. Here’s how leadership changes at the FDA can affect everyday life.